董关木

• 1:中国药品生物制品检定所疫苗一室 北京100050

摘要(Abstract)：

牛血清用于细胞培养已超过50年,虽然其污染外源因子的风险不能完全排除,但是至今许多贴壁细胞系和原代细胞还需采用添加牛血清的培养基进行大规模培养。本文综述了牛血清的基本营养成分、生长因子和其他功能性成分以及牛血清中最常见的外源病毒及应检测的病毒种类,并比较屠宰法和供体牛法获取血清的优缺点。

关键词(KeyWords)： 牛血清;血清成分;外源因子;细胞培养

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 董关木

DOI: 10.13200/j.cjb.2007.09.70.donggm.022

参考文献(References)：

• [1]Anonymous.Medical and healthcare marketplace guide.LexiNexisAcademic,1997,3:168-170.
• [2]Makoschey B,Patel JR,Van Gelder PTJA.Serum-free producedbovine Herpesvirus type 1 and bovine parainfluenza type 3 virus vac-cine are efficacious and safe.Cytotechnology,2002,39(3):139-145.
• [3]Makoschey B,Van Gelder PTJA,Keijsers V,et al.Bovine viral di-arrhea virus antigen in foetal calf serumbatches and consequences ofsuch contamination for vaccine production.Biologicals,2003,31:203-208.
• [4]Eagle H,Oyama VI,Levy M.Amino acid requirements of normaland malignant human cells in tissue culture.Arch Biochem Bio-phys,1957,67(2):432-446.
• [5]Shah G.Why do we still use serum in the production of biopharma-ceuticals.Animal sera derivatives and substitutes used in the manu-facture of pharmaceuticals:viral safety and regulatory aspects.DevBiol Stand,1999,99:17-22.
• [6]Wognum AW,Sol CJ,Van Der Noordaa J,et al.Isolation andcharacterization of a papovavirus from cynomolgus macaque kidneycells.Virol,1984,134(1):254-257.
• [7]Parry JV,Lucas MH,Richmond JE,et al.Evidence for a bovineorigin of polymaviruse detected infected rhesns kidney cells FRhK-4and 6.Archives Virol,1983,78(3):151-165.
• [8]Schuurman R,Van Steenis B,Van Strien A,et al.Frequent detec-tion of bovine polyomavirus in commercial batches of calf serum byusing the polymerase chain reaction.J.Gen Virol,1991,72(11):2739-2745.
• [9]Carron N,Archie L,Daniel NG,Detection of infectious bovinepolyomavirus.Biologicals,2003,31:303-306.
• [10]Brown F,Cartwright T,Horaud F,et al.Animal sera,animal seraderivatives and substitutes used in the manufacture of pharmaceuti-cal:viral safety and regulatory aspects.Dev Biol Stand,1999,99:45-47.
• [11]Irene G,Beatrice G,Volker M.Bovine viral diarrhea eradication andcontrol programmes in Europe.Biologicals,2003,31(2):113-118.
• [12]Makoschey B,Gelder P,Keijsers V,et al,Bovine viral diarrhoeavirus antigen in foetal calf serum batches and consequences of suchcontamination for vaccine production.Biologicals,2003,31(2):203-208.
• [13]Rufenacht J,Schaller P,Audige L,et al.The effect of infectionwith bovine viral diarrhea virus on the fertility of Swiss dairy cattle.Theriogenology,2001,56(2):199-210.
• [14]Moennig V,Liess B.Pathogenesis of intrauterine infection with bo-vine viral diarrhea virus.Vet Clin North Am Food Anim Pract,1995,11(2):477-487.
• [15]Brown F,Cartwright T,Horaud F,et al.Animal sera,animal sera de-rivatives and substitutes used in the manufacture of pharmaceutical:vi-ral safety and regulatory aspects.Dev Biol Stand,1999,99:3-8.
• [16]Radwan GS,Brock KV,Hogan JH,et al.Development of a PCRamplification assay as a screening test using bulk milk samples for i-dentifying dairy herds infected with bovine viral diarrhea virus.VetMicrobiol,1995,44(1):77-92.
• [17]Synge BA,Clark AM,Moar JA,et al.The control of bovine virusdiarrhoea virua in Shetland.Vet Microbiol,1999,64(2,3):223-229.
• [18]Bolin SR,Matthews PJ,Ridpath JF.Methods for the detection andfrequency of contamination of foetal calf serum with bovine viral di-arrhea virus and antibodies against bovine viral diarrhea virus.J VetInvest,1999,3(3):199-203.
• [19]Cartwright T.Animal cells as bioreactors.Cambridge UniversityPress,1994.41-58.
• [20]Villamediana P,Vidal F,Paramio,MT.Cytogenetic analysis ofcaprine 2-to 4-cell embryos produced in vitro.Zygote,2001,9(3):193-199.